Thrombospondin-1: Multiple paths to inflammation

Mediators of Inflammation

Volumn 2011, Issue , 2011, Pages

  Gutierrez, Linda S ^a   Lopez Dee, Zenaida ^a   Pidcock, Kenneth ^a  

^a WILKES UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD47 ANTIGEN; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VERY LATE ACTIVATION ANTIGEN 4;

ABSCESS; ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; B LYMPHOCYTE; BACTERIAL MENINGITIS; BASOPHIL; CAPILLARY PERMEABILITY; CARCINOGENESIS; CELL DAMAGE; CELL INFILTRATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CHRONIC INFLAMMATION; COLITIS; COLORECTAL CANCER; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAPEDESIS; DISEASE MODEL; DISEASE SEVERITY; DOWN REGULATION; DYSPLASIA; ENDOTHELIUM CELL; ENTERITIS; EXPERIMENTAL MODEL; FIBRIN DEPOSITION; FIBROBLAST; FIBROSIS; GENE EXPRESSION; GLOMERULOSCLEROSIS; HEALING; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY INFILTRATE; INSULIN RESISTANCE; INTESTINE PERFORATION; KIDNEY FIBROSIS; KIDNEY INJURY; LACRIMAL GLAND; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LEUKOCYTOSIS; LOBAR PNEUMONIA; LYMPHOCYTE; MACROPHAGE; MAST CELL; MOLECULAR INTERACTION; MONOCYTE; MONONUCLEAR CELL; MYOSITIS; NEUTROPHIL; NONHUMAN; PANCREATITIS; PERITONITIS; PHAGOCYTE; PHAGOCYTOSIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SCAR FORMATION; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TISSUE INJURY; UPREGULATION; VASODILATATION; WOUND HEALING; ACUTE DISEASE; ANIMAL; CHRONIC DISEASE; IMMUNE SYSTEM; IMMUNOLOGY;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; THROMBOSPONDIN 1;

EID: 80052333271     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2011/296069     Document Type: Review

References (103)

1. Lawler J., Slayter H., Coligan J. E., Isolation and characterization of a high molecular weight glycoprotein from human blood platelets Journal of Biological Chemistry 1978 253 23 8609 8616 (Pubitemid 9082569)
2. Wight T. N., Raugi G., Mumby S. M., Bornstein P., Light microscopic immunolocation of thrombospondin in human tissues Journal of Histochemistry and Cytochemistry 1985 33 4 295 302 (Pubitemid 15122786)
3. Naganuma H., Satoh H., Asahara T., Zhang L., Amagasaki K., Watanabe A., Satoh E., Nukui H., Kuroda K., Quantification of thrombospondin-1 secretion and expression of v 3 and 3 1 integrins and syndecan-1 as cell-surface receptors for thrombospondin-1 in malignant glioma cells Journal of Neuro-Oncology 2004 70 3 309 317 (Pubitemid 40057959)
4. Bornstein P., Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1 Journal of Cell Biology 1995 130 3 503 506
5. Tan K., Lawler J., The interaction of thrombospondins with extracellular matrix proteins Journal of Cell Communication and Signaling 2009 3 3-4 177 187
6. Chen H., Sottile J., Strickland D. K., Mosher D. F., Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1 Biochemical Journal 1996 318 3 959 963 (Pubitemid 26320965)
7. Calzada M. J., Sipes J., Krutzsch H. C., Yurchenco P. D., Roberts D. D., Annis D. S., Mosher D. F., Recognition of the N-terminal modules of thrombospondin-1 and thrombospondin-2 by 6 1 Integrin Journal of Biological Chemistry 2003 278 42 40679 40687 (Pubitemid 37280881)
8. Lawler J., Hynes R., The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins Journal of Cell Biology 1986 103 5 1635 1648 (Pubitemid 17189019)
9. Jiménez B., Volpert O., Crawford S. E., Febbraio M., Silverstein R. L., Bouck N., Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nature Medicine 2000 6 1 41 48 (Pubitemid 30048524)
10. Silverstein R. L., Baird M., Lo S. K., Yesner L. M., Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor Journal of Biological Chemistry 1992 267 23 16607 16612
11. Gruarin P., Thorne R., Dorahy D. J., Burns G. F., Sitia R., Alessio M., CD36 is a ditopic glycoprotein with the N-terminal domain implicated in intracellular transport Biochemical and Biophysical Research Communications 2000 275 2 446 454
12. Daviet L., Malvoisin E., Wild T. F., McGregor J. L., Thrombospondin induces dimerization of membrane-bound, but not soluble CD36 Thrombosis and Haemostasis 1997 78 2 897 901 (Pubitemid 27365591)
13. Martin C. A., Longman E., Wooding C., Hoosdally S. J., Ali S., Aitman T. J., Gutmann D. A.P., Freemont P. S., Byrne B., Linton K. J., Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins Protein Science 2007 16 11 2531 2541 (Pubitemid 350036758)
14. Crawford S. E., Stellmach V., Murphy-Ullrich J. E., Ribeiro S., Lawler J., Hynes R. O., Boivin G. P., Bouck N., Thrombospondin-1 is a major activator of TGF- 1 in vivo Cell 1998 93 7 1159 1170 (Pubitemid 28307421)
15. Young G. D., Murphy-Ullrich J., The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor- complex Journal of Biological Chemistry 2004 279 46 47633 47642 (Pubitemid 39540909)
16. Schultz-Cherry S., Chen F., Mosher D. F., Misenheimer T. M., Krutzsch H., Roberts D. D., Murphy-Ullrich J. E., Regulation of transforming growth factor- activation by discrete sequences of thrombospondin 1 Journal of Biological Chemistry 1995 270 13 7304 7310
17. Ali N. A., Gaughan A., Orosz C. G., Hunter M. G., Eubank T. D., Wang Y., Baran C. P., Lawler J., McMaken S., Marsh C. B., Lichtenberger F. J., Flavahan N. A., Latency associated peptide has in vitro and in vivo immune effects independent of TGF- 1 PLoS ONE 2008 3 4
18. Majluf-Cruz A., Manns J. M., Uknis A. B., Lawler J., Yang X., Harris R. B., Dela Cadena R. A., Colman R. W., Frazier W. A., Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays Journal of Laboratory and Clinical Medicine 2000 136 4 292 302
19. Hogg P. J., Owens D., Misenheimer T. M., Mosher D. F., Chesterman C. N., Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase Journal of Biological Chemistry 1993 268 10 7139 7146 (Pubitemid 23105603)
20. Margosio B., Rusnati M., Bonezzi K., Cordes B. L. A., Presta M., Urbinati C., Giavazzi R., Mosher D. F., Ribatti D., Annis D. S., Taraboletti G., Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain International Journal of Biochemistry and Cell Biology 2008 40 4 700 709 (Pubitemid 351288589)
21. Kosfeld M. D., Frazier W. A., Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin Journal of Biological Chemistry 1993 268 12 8808 8814 (Pubitemid 23118671)
22. Isenberg J. S., Ridnour L. A., Dimitry J., Frazier W. A., Wink D. A., Roberts D. D., CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1 Journal of Biological Chemistry 2006 281 36 26069 26080 (Pubitemid 44401813)
23. Isenberg J. S., Pappan L. K., Romeo M. J., Roberts D. D., Abu-Asab M. S., Frazier W. A., Tsokos M., Wink D. A., Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts Annals of Surgery 2008 247 1 180 190
24. Kaur S. M., Martin-Manso G., Pendrak M. L., Garfield S. H., Isenberg J. S., Roberts D. D., Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47 Journal of Biological Chemistry 2010 285 50 38923 38932
25. Grimbert P., Bouguermouh S., Baba N., Nakajima T., Allakhverdi Z., Braun D., Rubio M., Delespesse G., Saito H., Sarfati M., Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells-from human CD4+ CD25- T cells in response to inflammation Journal of Immunology 2006 177 6 3534 3541 (Pubitemid 44359884)
26. Doyen V., Rubio M., Braun D., Nakajima T., Abe J. I., Delespesse G., Saito H., Sarfati M., Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation Journal of Experimental Medicine 2003 198 8 1277 1283 (Pubitemid 37323392)
27. Isenberg J. S., Martin-Manso G., Maxhimer J. B., Roberts D. D., Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies Nature Reviews Cancer 2009 9 3 182 194
28. Wu F., Tyml K., Wilson J. X., iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells Journal of Cellular Physiology 2008 217 1 207 214
29. Pober J. S., Sessa W., Evolving functions of endothelial cells in inflammation Nature Reviews Immunology 2007 7 10 803 815 (Pubitemid 47480307)
30. Isenberg J. S., Ridnour L., Thomas D. D., Wink D. A., Roberts D. D., Espey M. G., Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradients Free Radical Biology and Medicine 2006 40 6 1028 1033 (Pubitemid 43376012)
31. Isenberg J. S., Frazier W. A., Roberts D. D., Thrombospondin-1: a physiological regulator of nitric oxide signaling Cellular and Molecular Life Sciences 2008 65 5 728 742
32. Kaipainen A., Kieran M., Huang S., Bielenberg D. R., Mulligan R. C., Panigrahy D., Butterfield C. E., Folkman J., Mostoslavsky G., PPAR deficiency in inflammatory cells suppresses tumor growth PLoS ONE 2007 2 2, article e260
33. Haviv F., Bradley M., Kalvin D. M., Haskell C., Hodde J., Surber B., Majest S., Wang Y., Davidson D. J., Leal J., Henkin J., Schneider A., Lesniewski R., McKay L. M., Ferrero J. L., Badylak S. F., Uchic J. T., Bell R. L., Nguyen B., Record R. D., Marsh K. C., Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities Journal of Medicinal Chemistry 2005 48 8 2838 2846 (Pubitemid 40548098)
34. Huang H., Campbell S. C., Bedford D. F., Nelius T., Shroff E. H., Veliceasa D., Volpert O. V., Henkin J., Schneider A., Bouck N., Peroxisome proliferator-activated receptor ligands improve the antitumor efficacy of thrombospondin peptide ABT510 Molecular Cancer Research 2004 2 10 541 550 (Pubitemid 39403382)
35. Greenaway J., Henkin J., Lawler J., Moorehead R., Petrik J., ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer Molecular Cancer Therapeutics 2009 8 1 64 74
36. Liu Y., Merlin D., Burst S. L., Pochet M. M., Madara J. L., Parkos C. A., The role of CD47 in neutrophil transmigration: increased rate of migration correlates with increased cell surface expression of CD47 Journal of Biological Chemistry 2001 276 43 40156 40166
37. Isenberg J. S., Roberts D. D., Frazier W. A., CD47: a new target in cardiovascular therapy Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 4 615 621 (Pubitemid 351651336)
38. Manna P. P., Dimitry J., Oldenborg P. A., Frazier W. A., CD47 augments fas/CD95-mediated apoptosis Journal of Biological Chemistry 2005 280 33 29637 29644 (Pubitemid 41177039)
39. Lawrence D. W., King S. B., Frazier W. A., Koenig J. M., Decreased CD47 expression during spontaneous apoptosis targets neutrophils for phagocytosis by monocyte-derived macrophages Early Human Development 2009 85 10 659 663
40. Torres-Aguilar H., Aguilar-Ruiz R. S., Gonzlez-Pérez G., Mungua R., Bajaa S., Meraz-Ros M. A., Snchez-Torres C., Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells Journal of Immunology 2010 184 4 1765 1775
41. Saban D. R., Bock F., Chauhan S. K., Masli S., Dana R., Thrombospondin-1 derived from APCs regulates their capacity for allosensitization Journal of Immunology 2010 185 8 4691 4697
42. Vallejo A. N., Mgge L., Klimiuk P. A., Weyand C. M., Goronzy J. J., Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells Journal of Immunology 2000 164 6 2947 2954 (Pubitemid 30148952)
43. Li S. S., Liu Z., Uzunel M., Sundqvist K. G., Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion Blood 2006 108 9 3112 3120
44. Mittal R., Gonzalez-Gomez I., Prasadarao N. V., Escherichia coli K1 promotes the ligation of CD47 with thrombospondin-1 to prevent the maturation of dendritic cells in the pathogenesis of neonatal meningitis Journal of Immunology 2010 185 5 2998 3006
45. Patel S. N., Lu Z., Ayi K., Serghides L., Gowda D. C., Kain K. C., Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo Journal of Immunology 2007 178 6 3954 3961 (Pubitemid 46417666)
46. Baranova I. N., Kurlander R., Bocharov A. V., Vishnyakova T. G., Chen Z., Remaley A. T., Csako G., Patterson A. P., Eggerman T. L., Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling Journal of Immunology 2008 181 10 7147 7156
47. Savill J. S., Dransfield I., Gregory C. D., Haslett C., A blast from the past: clearance of apoptotic cells regulates immune responses Nature Reviews Immunology 2002 2 12 965 975 (Pubitemid 37323217)
48. Lamy L., Foussat A., Brown E. J., Bornstein P., Ticchioni M., Bernard A., Interactions between CD47 and thrombospondin reduce inflammation Journal of Immunology 2007 178 9 5930 5939 (Pubitemid 46674390)
49. Becker C., Fantini M. C., Neurath M. F., TGF-beta as a T cell regulator in colitis and colon cancer Cytokine and Growth Factor Reviews 2006 17 1-2 97 106 (Pubitemid 43117519)
50. Monteleone G., Kumberova A., Croft N. M., McKenzie C., Steer H. W., Macdonald T. T., Blocking Smad7 restores TGF- 1 signaling in chronic inflammatory bowel disease Journal of Clinical Investigation 2001 108 4 601 609 (Pubitemid 32777740)
51. Beck P. L., Rosenberg I., Xavier R. J., Koh T. J., Wong J., Podolsky D. K., Transforming growth factor- mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells American Journal of Pathology 2003 162 2 597 608 (Pubitemid 36267866)
52. Kulkarni A. B., Thyagarajan T., Letterio J. J., Function of cytokines within the TGF- superfamily as determined from transgenic and gene knockout studies in mice Current Molecular Medicine 2002 2 3 303 327 (Pubitemid 34649849)
53. Leveen P., Larsson J., Ehinger M., Cilio C. M., Sundler M., Sjstrand L. J., Holmdahl R., Karlsson S., Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable Blood 2002 100 2 560 568 (Pubitemid 34761120)
54. Hugo C., Shankland S. J., Couser W., Johnson R. J., Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat Kidney International 1998 53 2 302 311 (Pubitemid 28097847)
55. Azuma A., Li Y., Abe S., Usuki J., Henmi S., Miyauchi Y., Izawa A., Matsuda K., Ueda K., Hashimoto S., Sone S., Kudoh S., Interferon- inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor- and thrombospondin American Journal of Respiratory Cell and Molecular Biology 2005 32 2 93 98 (Pubitemid 40189690)
56. Rhyu D. Y., Yang Y., Ha H., Lee G. T., Song J. S., Uh S. T., Lee H.B., Role of reactive oxygen species in TGF- 1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells Journal of the American Society of Nephrology 2005 16 3 667 675 (Pubitemid 41725103)
57. Xia Y. P., Li B., Hylton D. M., Detmar M., Yancopoulos G. D., Rudge J. S., Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis Blood 2003 102 1 161 168 (Pubitemid 36759650)
58. Turpie B., Yoshimura T., Gulati A., Masli S., Rios J. D., Dartt D. A., Sjgren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice American Journal of Pathology 2009 175 3 1136 1147
59. Lawler J., Short M., Thibert V., Duquette M., George E. L., Rayburn H., Hynes R. O., Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia Journal of Clinical Investigation 1998 101 5 982 992 (Pubitemid 28125276)
60. Xie X. S., Li F., Liu H. C., Deng Y., Li Z., Fan J. M., LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction Archives of Pharmacal Research 2010 33 2 275 284
61. McGregor B., Colon S., Mutin M., McGregor J. L., Chignier E., Zech P., Thrombospondin in human glomerulopathies: a marker of inflammation and early fibrosis American Journal of Pathology 1994 144 6 1281 1287 (Pubitemid 24172090)
62. Daniel C., Schaub K., Amann K., Lawler J., Hugo C., Thrombospondin-1 is an endogenous activator of TGF- in experimental diabetic nephropathy in vivo Diabetes 2007 56 12 2982 2989 (Pubitemid 350223633)
63. Frangogiannis N. G., Ren G., Dewald O., Zymek P., Haudek S. B., Koerting A., Michael L. H., Winkelmann K., Lawler J., Entman M. L., Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts Circulation 2005 111 22 2935 2942 (Pubitemid 40814186)
64. Moura R., Tjwa M., Vandervoort P., Van Kerckhoven S., Holvoet P., Hoylaerts M. F., Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE/ Mice Circulation Research 2008 103 10 1181 1189
65. Bhattacharyya S., Marinic T., Krukovets I., Hoppe G., Stenina O. I., Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose Journal of Biological Chemistry 2008 283 9 5699 5707
66. Varma V., Yao-Borengasser B. A., Bodies A. M., Rasouli N., Nagarajan R., Fried S. K., Lee M. J., Peterson C., Nolen G. T., Spencer H. J., Phanavanh B., McGehee R. E., Kern P. A., Kern E. M., Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance Diabetes 2008 57 2 432 439
67. Punekar S., Zak S., Kalter V. G., Dobransky L., Gutierrez L. S., Punekar I. R. A., Lawler J., Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease Pathobiology 2008 75 1 9 21 (Pubitemid 351365633)
68. Zak S., Treven J., Nash N., Gutierrez L. S., Lack of thrombospondin-1 increases angiogenesis in a model of chronic inflammatory bowel disease International Journal of Colorectal Disease 2008 23 3 297 304
69. Isenberg J. S., Yu C., Roberts D. D., Differential effects of ABT-510 and a CD36-binding peptide derived from the type 1 repeats of thrombospondin-1 on fatty acid uptake, nitric oxide signaling, and caspase activation in vascular cells Biochemical Pharmacology 2008 75 4 875 882
70. Gutierrez L. S., The role of thrombospondin 1 on intestinal inflammation and carcinogenesis Biomarker Insights 2008 2008 3 171 178 (Pubitemid 351514033)
71. Yehualaeshet T., O'Connor R., Begleiter A., Khalil N., Murphy-Ullrich J. E., Silverstein R. L., A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat American Journal of Respiratory Cell and Molecular Biology 2000 23 2 204 212 (Pubitemid 30656430)
72. Manns J. M., Uknis A. B., Rico M. C., Agelan A., Barbe M. F., Castaneda J. L., Safadi F. F., Popoff S. N., Arango I., Dela Cadena R. A., A peptide from thrombospondin 1 modulates experimental erosive arthritis by regulating connective tissue growth factor Arthritis and Rheumatism 2006 54 8 2415 2422 (Pubitemid 44205001)
73. Rico M. C., Castaneda J. L., Manns J. M., Sainz I. M., Safadi F. F., Uknis A. B., Popoff S. N., Dela Cadena R. A., Amelioration of inflammation, angiogenesis and CTGF expression in an arthritis model by a TSP1-derived peptide treatment Journal of Cellular Physiology 2007 211 2 504 512 (Pubitemid 46580104)
74. Stuhlmller B., Ungethm U., Scholze S., Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis Arthritis and Rheumatism 2000 43 4 775 790
75. Pohlers D., Brenmoehl J., Lffler I., Mller C. K., Kinne R. W., Leipner C., Schultze-Mosgau S., Stallmach A., Wolf G., TGF- and fibrosis in different organsmolecular pathway imprints Biochimica et Biophysica Acta 2009 1792 8 746 756
76. Rico M. C., Manns J. M., Driban J. B., Uknis A. B., Dela Cadena R. A., Kunapuli S. P., Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis Translational Research 2008 152 2 95 98
77. De Luna N., Domnguez-Perles R., Gallardo E., Sonnet C., Illa I., Chazaud B., Suarez-Calvet X., Gherardi R. K., Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy Journal of Neuropathology and Experimental Neurology 2010 69 6 643 653
78. Salajegheh M., Raju R., Schmidt J., Dalakas M. C., Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis Journal of Neuroimmunology 2007 187 1-2 166 174 (Pubitemid 47008931)
79. Masli S., Turpie B., Streilein J. W., Thrombospondin orchestrates the tolerance-promoting properties of TGF -treated antigen-presenting cells International Immunology 2006 18 5 689 699 (Pubitemid 43779059)
80. Olerud J., Johansson M., Lawler J., Welsh N., Carlsson P. O., Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets Diabetes 2008 57 7 1870 1877
81. Perkins N. D., Integrating cell-signalling pathways with NF- B and IKK function Nature Reviews Molecular Cell Biology 2007 8 1 49 62 (Pubitemid 46012014)
82. Libermann T. A., Baltimore D., Activation of interleukin-6 gene expression through the NF- B transcription factor Molecular and Cellular Biology 1990 10 5 2327 2334
83. De Stefano D., Nicolaus G., Maiuri M. C., Cipolletta D., Galluzzi L., Cinelli M. P., Carnuccio R., Tajana G., Iuvone T., NF- B blockade upregulates Bax, TSP-1, and TSP-2 expression in rat granulation tissue Journal of Molecular Medicine 2009 87 5 481 492
84. Streit M., Velasco P., Riccardi L., Spencer L. A., Lange-Asschenfeldt B., Yano K., Brown L. F., Detmar M., Hawighorst T., Iruela-Arispe L., Janes L., Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice EMBO Journal 2000 19 13 3272 3282 (Pubitemid 30428205)
85. Aurora A. B., Biyashev D., Mirochnik Y., Zaichuk T. A., Renault M. A., Losordo D. W., Snchez-Martinez C., Volpert O. V., NF- B balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement Blood 2010 116 3 475 484
86. Janabi M., Yamashita S., Hirano K. I., Nozaki S., Zhang Z., Sakai N., Matsumoto K., Matsuzawa Y., Hiraoka H., Oxidized LDL-induced NF- B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 8 1953 1960 (Pubitemid 30648813)
87. Nelius T., Filleur S., Yemelyanov A. Y., Budunova I. V., Aurora A., Wang Z., Shroff E. H., Mirochnik Y., Veliceasa D., Volpert O. V., Xiao W., Androgen receptor targets NF B and TSP1 to suppress prostate tumor growth in vivo International Journal of Cancer 2007 121 5 999 1008 (Pubitemid 47101635)
88. Gaurnier-Hausser A., Rothman V. L., Dimitrov S., Tuszynski G., The novel angiogenic inhibitor, angiocidin, induces differentiation of monocytes to macrophages Cancer Research 2008 68 14 5905 5914
89. Takeda K., Noguchi K., Shi W., Matsumoto M., Tanaka T., Akira S., Yoshida N., Kishimoto T., Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality Proceedings of the National Academy of Sciences of the United States of America 1997 94 8 3801 3804 (Pubitemid 27180453)
90. Akira S., IL-6-regulated transcription factors International Journal of Biochemistry and Cell Biology 1997 29 12 1401 1418 (Pubitemid 28153490)
91. Schuringa Jonk J. L., Dokter W. H. A., Vellenga E., Jonk L. J., Kruijer W., Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components Biochemical Journal 2000 347 1 89 96 (Pubitemid 30199045)
92. Becker C., Fantini M. C., Schramm C., Huber S., Strand S., Blessing M., Wirtz S., Burg J., Nikolaev A., Lehr H. A., Ito H., Kishimoto T., Rose-John S., Galle P. R., Kiesslich R., Yoshizaki K., Neurath M. F., Nishimoto N., TGF- suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 2004 21 4 491 501 (Pubitemid 39370505)
93. Rose-John S., Mitsuyama K., Matsumoto S., Thaiss W., Scheller J., Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease Current Pharmaceutical Design 2009 15 18 2095 2103
94. Weber A., Hengge U. R., Stricker I., Tischoff I., Anhalt K., Tannapfel A., Dietz A., Markwart A., Wittekind C., Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas Human Pathology 2007 38 2 228 238 (Pubitemid 46096547)
95. Nye D., Lopez-Dee Z., Simone C., Papathomas K., Ling J., Gutierrez L. S., Thrombospondin 1 regulates interleukin 6 by an angiogenic mechanism mediated by TGFbeta1 Inflammatory Bowel Disease 2009 15 S1 S65
96. Garside S. A., Henkin J., Morris K. D., Norvell S. M., Thomas F. H., Fraser H. M., A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo Endocrinology 2010 151 12 5905 5915
97. Eckmann L., Nebelsiek T., Fingerle A. A., Dann S. M., Kagnoff M. F., Karin M., Greten F., Schmid R. M., Mages J., Robine S., Arkan M. C., Lang R., Opposing functions of IKK during acute and chronic intestinal inflammation Proceedings of the National Academy of Sciences of the United States of America 2008 105 39 15058 15063
98. Leung L. L. K., Li W. X., McGregor J. L., Albrecht G., Howard R. J., CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction Journal of Biological Chemistry 1992 267 25 18244 18250
99. Yamauchi Y., Kuroki M., Imakiire T., Uno K., Abe H., Beppu R., Yamashita Y., Kuroki M., Shirakusa T., Opposite effects of thrombospondin-1 via CD36 and CD47 on homotypic aggregation of monocytic cells Matrix Biology 2002 21 5 441 448 (Pubitemid 35286610)
100. Feng J., Han J., Pearce F. A., Silverstein R. L., Gotto Jr. A. M., Hajjar D. P., Nicholson A. C., Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ Journal of Lipid Research 2000 41 5 688 696
101. Majai G., Sarang Z., Csomos K., Zahuczky G., Fesus L., PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells The European Journal of Immunology 2007 37 1343 1354 (Pubitemid 46925318)
102. Szanto A., Nagy L., Retinoids potentiate peroxisome proliferator- activated receptor action in differentiation, gene expression, and lipid metabolic processes in developing myeloid cells Molecular Pharmacology 2005 67 6 1935 1943 (Pubitemid 41007775)
103. Murphy-Ullrich J. E., Schultz-Cherry S., Hk M., Transforming growth factor-beta complexes with thrombospondin Molecular Biology of the Cell 1992 3 181 188 (Pubitemid 23084549)